Aus, NZ propose key features of joint ANZTPA regulations for devices, drugs
This article was originally published in Clinica
Executive Summary
Regulatory agencies in Australia and New Zealand are inviting feedback on "high-level" features of a possible common framework for regulating medical devices, drugs, biologics and other therapeutic products under the ANZTPA – the joint scheme that is being established to regulate therapeutic products in both countries.